gip and glp-1 receptors Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research GLP-1 Receptor Agonists Explained for
Description
The relative risk came out to 0.76, with a confidence interval of 0.42 to 1.36
Newsome, P
To examine molecular mechanisms of this phenomenon, exendin (939)specific inhibitor of GLP-1 receptor, Rp-cAMPthe cAMP inhibitor, PI3 K inhibitor LY294002 or p44/42 mitogen-activated protein kinase inhibitor UO126, were given concomitantly with GLP-1 + VP infusion
But read the fine print first
